Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: Aphria (TSX: APHA) (NYSE: APHA), Choom (CSE: CHOO), Aurora (TSX: ACB) (NYSE: ACB), FSD Pharma (CSE: HUGE), Khiron (TSXV: KHRN), Green Growth (CSE: GGB) and Nextleaf (CSE: OILS)

 

Delta, Kelowna, BC - March 28, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/032819-StocksToWatch.mp3

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: Aphria (TSX: APHA) (NYSE: APHA), Choom (CSE: CHOO), Aurora (TSX: ACB) (NYSE: ACB), FSD Pharma (CSE: HUGE), Khiron (TSXV: KHRN), Green Growth (CSE: GGB) and Nextleaf (CSE: OILS)

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we are looking at announcements from Aphria Inc. (TSX: APHA) (NYSE: APHA), Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF), Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB), FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF), Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF), Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) and Nextleaf Solutions Ltd. (CSE: OILS).

Aphria Inc. announced that it will release financial results for the fiscal third quarter and nine months ended February 28, 2019 on April 15, 2019 before market open.

Choom Holdings Inc., an emerging adult and medical use cannabis company that has secured one of the largest national retail networks in Canada, announced that it has signed a memorandum of understanding with Better Choice Company, Inc. for the exclusive Canadian distribution rights to Better Choice's CBD Bona Vida brand of products targeted for animal health and wellness once approved for sale in Canada. The terms of the MOU are not material.

According to the American Pet Products Association, U.S. pet owners are estimated to have spent over $70 billion in 2018 on pet supplies, treatments and veterinary care. As CBD pet products become more readily available and accepted, well positioned suppliers and distributors will be able to exploit the tremendous opportunities for growth in the CBD pet sales.

Under its Bona Vida brand, Better Choice offers a suite of CBD pet focused products in the form of oils and soft chews with several formulations designed to aid the state of good health and well-being in pets. Bona Vida has formulations which specifically target animals Relaxation & Heart Support, Muscle & Joint, as well as, Skin & Body.

"We are excited that Better Choice has chosen us as their exclusive distributor in Canada for their pet focused CBD products," states Chris Bogart, President and CEO of Choom. "We recognize the importance of growing our brand portfolio and having the sole distribution rights for Better Choice products helps us achieve that in an entirely new market on the horizon in pet use products. From what we know of in the United States, the CBD products for pet use market has proven to be a high margin business. As the normalization of cannabis-based products in Canada grows, consumers will begin to shift towards these new natural alternative treatments for their pets."

Aurora Cannabis Inc. announced today that the Company and its wholly-owned subsidiary CanniMed Therapeutics, have added product information numbers (PINs) to 78 medical cannabis products to better facilitate and track insurance coverage for their Canadian patients. The products that received PINs include dried flower, capsules, soft gels, topicals and oils.

PINs help employers and insurance companies classify and incorporate health care products into benefit coverage plans. Patients submitting claims to their third-party insurer can now identify specific products and thereby speed up the adjudication and medical coverage process. MedReleaf, another wholly-owned subsidiary of Aurora, introduced PINs to 57 medical cannabis products in 2018.

"This is great news for insurance companies, employers and most importantly our patients," said Aurora CEO Terry Booth. "Introducing PINs for medical cannabis products will make the claims process more seamless, enabling insurance companies to add these products to their formularies while providing patients and employers with a simplified process to complete claims. It's another step toward enhancing patient access, something Aurora cares deeply about."

FSD Pharma Inc. announced today the signing of a consulting agreement with Joseph L. Romano, a well-respected lawyer with a strong track-record in personal injury law. Mr. Romano has been working with medical cannabis since 2006, assisting people coping with chronic pain to have access to medical cannabis, a viable alternative to opioid based medications.

Pursuant to the terms of the agreement, Mr. Romano will provide consulting on the inner workings of third party actions, WSIB claim handling, first party coverage and no fault benefits across Canada. Mr. Romano will also assist in identifying strategic acquisitions that will enhance shareholder value.

Commenting on the agreement, Dr. Raza Bokhari, Executive Co-Chairman and interim CEO said, "We are very excited to engage Mr. Romano in advance of our anticipated sales license. This is a very timely and important agreement for FSD Pharma to maximize the opportunities in the Canadian market for our products and fits well with our strategy of establishing the company as a leader in medical cannabis."

Khiron Life Sciences Corp., a vertically integrated cannabis leader with core operations in Latin America, announced today its participation, through Matt Murphy's appointment, in the newly formed National Cannabis Roundtable ("NCR"), a campaign aimed at reforming US federal cannabis laws. The NCR will focus on advocating for a rational legal framework for cannabis reform in the US with former Speaker of the House, John Boehner, serving as Honorary Chairman.

Matt Murphy, Khiron Vice President of Compliance, who will represent the Company on the NCR, stated, "With two-thirds of Americans indicating support for legalization of cannabis in some form, and safety and security being central to our mission across the entire supply chain, we believe that now is the time to work alongside our colleagues to inform and advocate for an open market that improves lives, creates jobs and establishes a national cannabis industry for the 21st century."

As Vice President of Compliance for Khiron and former Chief of Pharmaceutical Investigations for the U.S. Drug Enforcement Administration ("DEA"), Mr. Murphy is an executive leader with broad based domestic and international expertise in both the federal and private sectors. As a career Special Agent with the DEA for 25 years, he served in a multitude of positions in the fields of drug law enforcement, risk assessment and system development, regulatory compliance, and training. Mr. Murphy directs the Company's compliance activity by implementing closed loop systems to prevent product diversion and to enhance standard operating procedures across Khiron's plant-to-patient value chain based on the DEA protocols used to enforce compliance for the handling and distribution of controlled substances in the U.S.

Green Growth Brands, Inc. announced the opening of its newest Seventh Sense Botanical Therapy CBD shop today at Mayfair Mall in Greater Milwaukee, a Brookfield Properties center. This new location represents the sixth Seventh Sense Shop to open in the United States.

"Mayfair Mall is the premier mall in Greater Milwaukee and we look forward to bringing a remarkable CBD store experience to new customers in the region," said Peter Horvath, CEO of Green Growth Brands. "Physical shops are our strongest marketing assets, and our presence in the new location will drive hundreds-of-thousands impressions with consumers. As we gear-up to open over 100 CBD shops by mid-summer we are pleased with early signs of conversion, repeat purchases and building engagement with our current shops and online with ShopSeventhSense.com."

Nextleaf Solutions Ltd. announced that it has been issued a patent by the United States Patent and Trade Office pertaining to the Company's proprietary process of extraction, refinement, and distillation of cannabinoids from marijuana and hemp.

The resulting THC or CBD distillate is tasteless, odourless, standardized for potency, and ready to use in a wide range of products, including topicals, transdermal or sublingual delivery technology, vape technology, edible oils, beverages, and water-soluble extracts. Nextleaf's patented technology allows for low-quality dried cannabis biomass to be efficiently processed into a high-purity distilled oil, simplifying the manufacturing of differentiated cannabinoid formulations and delivery methods.

Nextleaf further announced that it has been issued a standard patent by IP Australia - the Australian Government agency that administers intellectual property ("IP") rights - for the Company's unique, industrial-scale process of producing purified cannabinoid distillate.

The Company's management believes, to the best of its knowledge, that Nextleaf is the first publicly traded company to be issued a patent for the extraction and purification of cannabinoids.

"Nextleaf Solutions has succeeded in beating big pharma, big tobacco, big alcohol, and every single billion-dollar cannabis company to the first issued patent for the extraction and purification of cannabinoids." said Paul Pedersen, CEO. "We believe companies that can develop and protect valuable intellectual property will benefit substantially in the long-term, especially in an industry as young as the cannabis industry."

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas podcasts

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708


Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/


About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.

Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Contact Investorideas.com

800-665-0411